MZE829

· Maze Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MZE829, covering 2026-04-17 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease [Phase 2]